Cover Image

Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy

Polypharmacy (PP) is a common problem in modern medicine, especially known to affect patients with chronic diseases such as multiple sclerosis (MS). With an increasing number of drugs taken, the risk of potential drug-drug interactions (pDDIs) is rising. This study aims to assess the prevalence and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paula Bachmann (Author), Niklas Frahm (Author), Jane Louisa Debus (Author), Pegah Mashhadiakbar (Author), Silvan Elias Langhorst (Author), Barbara Streckenbach (Author), Julia Baldt (Author), Felicita Heidler (Author), Michael Hecker (Author), Uwe Klaus Zettl (Author)
Format:	Book
Published:	MDPI AG, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis
by: Jane Louisa Debus, et al.
Published: (2022)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
by: Michael Hecker, et al.
Published: (2022)

Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
by: Marie-Celine Haker, et al.
Published: (2023)

Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
by: Michael Hecker, et al.
Published: (2023)

Challenges in monitoring the quality of care in multiple sclerosis
by: Uwe Klaus Zettl, et al.
Published: (2024)

Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
by: Tobias Zrzavy, et al.
Published: (2021)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
by: Bianca Papotti, et al.
Published: (2021)

Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population
by: Carla Bastida, et al.
Published: (2017)

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
by: Maria Cristina Soares Rodrigues, et al.

Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
by: Salamone S, et al.
Published: (2022)

Polypharmacy and potential drug-drug interactions among Greenland's care home residents
by: Nadja Albertsen, et al.
Published: (2022)

Evaluation of Polypharmacy and Drug Interactions in the Treatment of Patients with Sepsis
by: Nursel Sürmelioğlu, et al.
Published: (2021)

Warfarin and Polypharmacy Challenges in Sudan: Drug Interactions in Patient Cohort
by: Omer AAA, et al.
Published: (2024)

Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy
by: Adela Martín-Oliveros PhD Pharma, et al.
Published: (2024)

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
by: Niklas Frahm, et al.
Published: (2022)

The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
by: Mohammad B. Nusair, et al.
Published: (2020)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
by: Juveriya Farooq, et al.
Published: (2023)

Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug-Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
by: Antonio Martocchia, et al.
Published: (2020)

Pharmacotherapy in a Multidisciplinary Paediatric Hospital: Polypharmacy and Drug-Drug Interaction Risk Illustrated with a Clinical Case
by: M. N. Kostyleva, et al.
Published: (2022)

Rationale, design, and methodology of the EPIC (Epidemiology of Polypharmacy and Potential Drug-Drug Interactions in Elderly Cardiac Outpatients) study
by: Eda Özlek, et al.
Published: (2019)

Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention
by: Siobhán McGettigan, et al.
Published: (2024)

Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
by: Sofia Burato, et al.
Published: (2021)

Tripled likelihood: polypharmacy increases the occurrence of drug therapy problems in hospitalized pediatric patients
by: Bereket Takele, et al.
Published: (2024)

Polypharmacy and Drug Use Pattern among Indonesian Elderly Patients Visiting Emergency Unit
by: Czeresna Heriawan Soejono, et al.
Published: (2021)

Individual Pharmacotherapy Management (IPM)-IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy
by: Ursula Wolf, et al.
Published: (2022)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
by: Assefa YA, et al.
Published: (2020)

A Drug Safety Concept (I) to Avoid Polypharmacy Risks in Transplantation by Individual Pharmacotherapy Management in Therapeutic Drug Monitoring of Immunosuppressants
by: Ursula Wolf
Published: (2023)

Overview of Polypharmacy and Drug Interactions in Chronic Kidney Disease Patients at Siloam Hospitals Lippo Village
by: Anastasia Pramitaningastuti
Published: (2024)

Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
by: Dario Cattaneo, et al.
Published: (2023)

Opioids, Polypharmacy, and Drug Interactions: A Technological Paradigm Shift Is Needed to Ameliorate the Ongoing Opioid Epidemic
by: Adriana Matos, et al.
Published: (2020)

Complex Emulsions as an Innovative Pharmaceutical Dosage form in Addressing the Issues of Multi-Drug Therapy and Polypharmacy Challenges
by: Naresh Yandrapalli
Published: (2024)

Polypharmacy, potentially serious clinically relevant drug‐drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life
by: Labib AL‐Musawe, et al.
Published: (2020)

Polypharmacy and the occurrence of potential drug-drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
by: Adetola Olaniyi Bojuwoye, et al.
Published: (2022)

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
by: Weipeng Wei, et al.
Published: (2021)

Risk of Antiepileptic Drug Withdrawal in Tuebrous Sclerosis
by: J Gordon Millichap
Published: (2003)

POLYPHARMACY: RESPONSE
by: S. O. Kluchnikov
Published: (2015)

Polypharmacy in the elderly
by: Negar Golchin, et al.
Published: (2015)

Polypharmacy: An Overview
by: Nelisa Paidamwoyo Ganga
Published: (2022)

Exploring polypharmacy phenomenon in newly diagnosed relapsing-remitting multiple sclerosis: a cohort ambispective single-centre study
by: Aurora Zanghì, et al.
Published: (2021)

Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic "Time-Effect-Drug Administration" to Eliminate Adverse Drug Event (Case Report)
by: G. S. Krasnov, et al.
Published: (2018)